N.J. Admin. Code § 10:167A-1.23

Current through Register Vol. 57, No. 1, January 6, 2025

Section 10:167A-1.23 - Bundled drug service

(a) "Bundled drug service" means a drug or service that is marketed or distributed by the manufacturer or distributor as a combined package which includes in the cost the drug product and ancillary services such as, but not limited to, case management services and laboratory testing.

(b) Bundled drug service shall not be eligible for reimbursement by the PAAD program. The cost of the drug product which is a component of a bundled drug service (see N.J.A.C. 10:167A-1.14, Covered Pharmaceutical Services) shall be covered by the PAAD program.

Amended by R.1998 d.464, effective 9/8/1998.
See: 30 N.J.R. 2197(a), 30 N.J.R. 3309(a).
Recodified from N.J.A.C. 8:83C-1.21 and amended by R.2003 d. 248, effective 6/16/2003.
See: 34 N.J.R. 3456(a), 35 N.J.R. 2642(a).

Amended by 49 N.J.R. 446(a), effective 3/6/2017